Addex Therapeutics Ltd
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Values in USD · ADR · Reports in CHF
Addex Therapeutics Ltd ADS
Did you know?
Capital expenditures decreased by 83% from FY23 to FY24.
Current Price
—
Profile
Valuation (TTM)
Market Cap—
P/E—
EV—
P/B—
Shares Out—
P/Sales—
Revenue—
EV/EBITDA—
Addex Therapeutics Ltd (ADXN) Stock Analysis
Market Cap—
Current Price—
P/E Ratio—
Forward P/E—
PEG Ratio—
EPS—
Book Value—
P/B Ratio—
ADXN Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Cash: 4M
Revenue
7M
FY18
3M
FY19
4M
FY20
3M
FY21
2M
FY22
2M
FY23
—
FY24
Net Income
—
FY18
—
FY19
—
FY20
—
FY21
—
FY22
—
FY23
8M
FY24
Did you know?
ADXN's revenue grew at a -36.3% CAGR over the last 6 years.
Addex Therapeutics Ltd (ADXN) Financial Summary
Addex Therapeutics Ltd (ADXN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ..
..
ADXN Key Financial Metrics
| Metric | Value |
|---|
ADXN Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY18 | $6.84M | $-1.68M |
| FY19 | $2.92M | $-15.24M |
| FY20 | $4.41M | $-14.61M |
| FY21 | $3.47M | $-16.87M |
| FY22 | $1.55M | $-22.37M |
| FY23 | $1.93M | $-12.57M |
| FY24 | $455602.22 | $7.84M |
About Addex Therapeutics Ltd
Addex Therapeutics Ltd ADS